The Fed cuts rates by a quarter point as expected, but lowered expectations for a cuts in 2025 and boosted inflation ...

Investors' optimism about the stock market decreased for the second consecutive week, with sentiment shifting towards cautiousness amid Fed policy ...

PeptiDream's proprietary PDPS platform offers a promising investment opportunity due to the new therapeutic class of ...

Societe Generale trades at a significant discount to its European peers due to weak fundamentals and poor earnings momentum, ...

Starwood Property Trust (STWD) extends debt maturity, lowers borrowing costs, and increases liquidity for investing in 2025 ...

Tesla is now fully valued after the EV maker's shares have surged since the election. Click here to find out why I think BYD ...

Fed's December 25 bps rate cut to 4.25-4.50% was expected, but the hawkish SEP projections caused a harsh market reaction.

Finnish health tech firm Oura has closed a $200M Series D funding round that boosts its market valuation to $5.2B. The smart ...

Tesla has emerged victorious from a rough two years, as the Trump victory rally has fueled euphoria in TSLA stock. Find out ...

My initial rating of leading egg producer Cal-Maine Foods is a hold, as the upside factors are overshadowed by the share ...

Zymeworks' transformation and execution have positioned them for success, with new drug approvals and promising phase 3 ...

This week, the markets saw mixed results with the S&P 500 declining by -0.52% and the Nasdaq climbing 0.47%. Discover more ...